Expert Exchange Interviews

See all Expert Exchange Interviews

 

 

Current Articles

Volume 10, Issue 1

Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP.3.3 From Approved Monoclonal Antibodies
Published: September 30, 2024 | 10.20411/pai.v10i1.752


Volume 9, Issue 2

Jonathan Yewdell Discusses Viral Immunology, Vaccine Development, Navigating a Scientific Career, and Offers Perspectives on Transforming Scientific Publishing and Research Education
Published: September 27, 2024 | 10.20411/pai.v9i2.753


Dr. Anthony Fauci Shares Insights on His Career and Leadership of the NIAID
Published: September 16, 2024 | 10.20411/pai.v9i2.754


Effect of Ceftaroline, Ceftazidime/Avibactam, Ceftolozane/Tazobactam, and Meropenem/Vaborbactam on Establishment of Colonization by Vancomycin-Resistant Enterococci and Klebsiella pneumoniae in Mice
Published: September 24, 2024 | 10.20411/pai.v9i2.711


People Living With HIV Have More Intact HIV DNA in Circulating CD4+ T Cells if They Have History of Pulmonary Tuberculosis
Published: September 23, 2024 | 10.20411/pai.v9i2.722


Sensitivity Analysis of C. auris, S. cerevisiae, and C. cladosporioides by Irradiation with Far-UVC, UVC, and UVB
Published: September 4, 2024 | 10.20411/pai.v9i2.723


Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response
Published: August 21, 2024 | 10.20411/pai.v9i2.718


Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody Treatment
Published: August 15, 2024 | 10.20411/pai.v9i2.715


Diagnostic Utility of Pre-Genomic Hepatitis B RNA in the Evaluation of HBV/HIV Coinfection
Published: July 30, 2024 | 10.20411/pai.v9i2.720


A Transcriptomic Biomarker Predicting Linezolid-Associated Neuropathy During Treatment of Drug-Resistant Tuberculosis
Published: June 25, 2024 | 10.20411/pai.v9i2.705


Characteristics and Functions of Infection-enhancing Antibodies to the N-terminal Domain of SARS-CoV-2
Published: June 18, 2024 | 10.20411/pai.v9i2.679

 

 

Interested in submitting to this journal?

Pathogens and Immunity is an open access journal that publishes original research, reviews and commentaries focused on pathogens, host defenses, and other clinically relevant aspects of immunity. Pathogens and Immunity does not charge fees to authors.

  • Online submissions are rapid (less than 5 minutes).
  • Currently there are no charges to authors for submission or publication.
  • We review submissions in any National Library of Medicine-approved format.
  • Manuscripts only need to be revised to fit the journal format if accepted.
  • Reviewers receive a modest cash payment for reviews completed in a timely manner.
  • Authors may, if they wish, provide unedited complete reviews from another named journal together with their response to these critiques that may assist in the review.
  • Articles are indexed on PubMed, PubMed Central, Google Scholar and the Directory of Open Access Journals.

We recommend that you review the About the Journal page for the journal's policies, as well as the Author Guidelines.

 

Previous Issues